Status:
COMPLETED
Performance Evaluation of the Nanomix eLab® CRP, PCT, and LAC Assays With the Nanomix eLab System
Lead Sponsor:
Nanomix
Conditions:
Sepsis
SIRS
Eligibility:
All Genders
18+ years
Brief Summary
The performance of the eLab C-Reactive Protein, Procalcitonin, and Lactate Assays will be demonstrated during a method comparison study in which venous whole blood and plasma samples are used. eLab re...
Eligibility Criteria
Inclusion
- Must be 18 years of age or older
- Must have provided written informed consent
- Admitted to ICU, Emergency Department or other medical wards for acute illness and observation of infection and meeting SIRS criteria (such as elevated heart rate, tachypnea, hypotension, fever, hypothermia, or elevated respiratory rate)
Exclusion
- Pregnant or nursing
- Admitted to ICU after trauma
- Admitted to ICU after surgery
- Cardiogenic shock
Key Trial Info
Start Date :
December 11 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
184 Patients enrolled
Trial Details
Trial ID
NCT03876535
Start Date
December 11 2018
End Date
August 30 2019
Last Update
August 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCSF- San Francisco General Hospital
San Francisco, California, United States, 94110